logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
I

In Hae Park

seoul national university
H指数:36
被引数:5,998

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies

曲妥珠单抗-pkrb联合吉地洛昔布在HER2阳性转移性乳腺癌患者中的II期研究，该患者在接受两种或更多HER2靶向治疗后进展

ESMO Open
IF8.3
2026-07-011
OAAI
Kim, J. W.; Park, V. H.; Lee, S.; Ahn, H. K.; Bae, J.; Park, S.; Chae, H.; Kim, J. H.; Lee, K. -h.; Kim, M. H.; Lee, K. E.; Kang, M. J.; Park, I. H.; Chae, V. s.; Lee, G. W.; Park, K. U.; Lee, E. M.; Park, J. H.; Kim, J. E.; Kim, H. K.; Kim, T. H.; Oh, S. V.; Ko, S.; Byun, J. H.; Ha, J. V.; Kwon, J. H.; Choi, J. V.; Jung, J. V.; Park, K. H.
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)

MIRINAE试验（一项比较辅助阿替利珠单抗联合卡培他滨与单用卡培他滨的随机II期试验；KCSG-BR18-21）中，新辅助化疗后残留浸润性三阴性乳腺癌的基因组学和转录组学分析

ESMO Open
IF8.3
2025-09-240
PREAI
S.-A. Im; K. Park; J. Koh; C. Park; K.H. Jung; J. Lee; H.K. Ahn; A. Lee; S.H. Sim; M.H. Kim; J.H. Kim; J.H. Kim; K.E. Lee; K.H. Park; J. Bae; M.H. Lee; S. Lim; H.J. Kim; D.-W. Lee; J.H. Jeong; K.S. Lee; J. Sohn; K.J. Suh; J.-Y. Kim; Y.J. Cha; J. Moon; C.-Y. Ock; S.-B. Kim; K. Shin; H. Chae; G.M. Kim; K.-H. Lee; W.-Y. Park; Y.H. Park; I.H. Park
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15)

韩国全国范围内帕博西利（palbociclib）在HR（+）、HER2（−）转移性乳腺癌患者中的真实世界实践模式与临床数据（KCSG BR21-15）

breast
IF0
2025-05-120
OA
Jieun Lee; Dae-Won Lee; Min Hwan Kim; Jee Hung Kim; Ju Won Kim; Jae-Ho Byun; Kyoung Eun Lee; Myoung Joo Kang; Su-Jin Koh; Soojung Hong; Hye Sung Won; Han Jo Kim; In Hae Park; Seong Hoon Shin; Sun Kyung Baek; Seul-Gi Kim; Sung Ae Koh; Joo Young Jung; Ji-Yeon Kim; Gun Min Kim; Yeon Hee Park
Comparison of clinical efficacy between letrozole plus ribociclib vs. Fulvestrant plus letrozole plus ribociclib in Hormone receptor positive, HER2 negative metastatic breast cancer - a randomized, phase 2 study (KCSG BR22-20)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Lee, Jieun; Koh, Su-Jin; Kwon, Jung Hye; Kim, Gun Min; Kim, Jee Hung; Kim, Ho Young; Kim, Hee-Jun; Park, Keon-Uk; Park, Kyong Hwa; Park, Yeon Hee; Ahn, Mi Sun; Ahn, Hee Kyung; Lee, Gyeong-Won; Lee, Kyoung Eun; Lee, Kyung-Hun; Lee, Moon Hee; Lee, Sung Sook; Lee, Jung Lim; Jung, Kyung Hae; Jung, Joo Young; Park, In Hae
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15)
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-01-280
OAAI
Baek, Sun Kyung; Jeong, Jae-ho; Jung, Kyunghae; Ahn, Hee Kyung; Kim, Min Hwan; Sohn, Joohyuk; Park, In Hae; Ahn, Jin Seok; Lee, Dae-Won; Im, Seock-Ah; Sim, Sung Hoon; Lee, Keun Seok; Hyun Kim, Jee; Shim, Hyun-Jeong; Chae, Yeesoo; Koh, Su-Jin; Lee, Hyorak; Lee, Jieun; Byun, Jae-Ho; Seol, Youngmi; Lee, Eun Mi; Jee, Hee-Jung; An, Hyonggin; Park, Eun Byeol; Suh, Young Ju; Lee, Kyoung Eun; Park, Yeon Hee
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer
CLINICAL CANCER RESEARCH
IF10.2
2023-11-225
OAAI
Cescon, David W.; Hilton, John; Morales Murilo, Serafin; Layman, Rachel M.; Pluard, Timothy; Yeo, Belinda; Park, In Hae; Provencher, Louise; Kim, Sung-Bae; Im, Young-Hyuck; Wyce, Anastasia; Krishnatry, Anu Shilpa; Hicks, Kirsty; Zhang, Qu; Barbash, Olena; Khaled, Ahmed; Horner, Thierry; Dhar, Arindam; Oliveira, Mafalda; Sparano, Joseph A.
Prevalence of germline BRCA mutations in unselected Korean patients with HER2-negative breast cancer: A Prospective cohort study
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Ahn, Hee Kyung; Kim, Jee Hung; Kim, Mirae; Park, Seri; Koh, Su-Jin; Sohn, Joo Hyuk; Kang, Myoung Joo; Jung, Kyung Hae; Lee, Kyoung Eun; Lee, Jieun; Koh, Sung Ae; Chae, Yee Soo; Byun, Jae Ho; Park, In Hae; Kim, Hee-Jun; Kim, Jee Hyun; Kim, Han Jo; Jung, Joo Young; Lee, Jung Lim; Cho, Yoon Young; Park, Kyong Hwa; Kim, Ji-Yeon; Im, Seock-Ah; Park, Yeon Hee
Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group

基于电子病历的真实世界数据的数据收集框架，以评估癌症药物的有效性和安全性: 韩国癌症研究小组的一项全国性真实世界研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2022-11-022
OAAI
Han, Hye Sook; Lee, Kyoung Eun; Suh, Young Ju; Jee, Hee-Jung; Kim, Bum Jun; Kim, Hyeong Su; Lee, Keun-Wook; Ryu, Min-Hee; Baek, Sun Kyung; Park, In Hae; Ahn, Hee Kyung; Jeong, Jae Ho; Kim, Min Hwan; Lee, Dae Hyung; Kim, Siheon; Moon, Hyemi; Son, Serim; Byun, Ji-Hye; Kim, Dong Sook; An, Hyonggin; Park, Yeon Hee; Zang, Dae Young
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+metastatic breast cancer (KCSG BR 18-14/KM10B)
BREAST
IF7.9
2022-10-012
OAAI
Sim, Sung Hoon; Kim, Jeong Eun; Kim, Min Hwan; Park, Yeon Hee; Kim, Jee Hyun; Suh, Koung Jin; Koh, Su-Jin; Park, Kyong Hwa; Kang, Myoung Joo; Ahn, Mi Sun; Lee, Kyoung Eun; Kim, Hee -Jun; Ahn, Hee Kyung; Kim, Han Jo; Park, Keon Uk; Byun, Jae Ho; Park, Jin Hyun; Lee, Gyeong-Won; Lee, Keun Seok; Sohn, Joohyuk; Jung, Kyung Hae; Park, In Hae
A nationwide real-world study for evaluation of efficacy and safety of T-DM1 in patients with HER2-positive locally-advanced unresectable or metastatic breast cancer in Korea (KCSG BR19-15)
CANCER RESEARCH
IF16.6
2022-02-150
PRE
Baek, Sun Kyung; Jeong, Jae-Ho; Park, Yeon-Hee; Ahn, Hee Kyung; Kim, Min Hwan; Park, In Hae; Suh, Young Ju; Lee, Dae-Won; Sim, Sung Hoon; Kim, Jee Hyun; Shim, Hyun-Jeong; Chae, Yeesoo; Koh, Su-Jin; Lee, Hyorak; Lee, Jieun; Byun, Jae-Ho; Seol, Youngmi; Lee, Eun Mi; Ahn, Jin Seok; Jung, Kyung-Hae; Im, Seock-Ah; Lee, Keun Seok; Sohn, Joohyuk; Lee, Kyoung Eun

研究方向

暂未获取到该数据
K
Keun Seok Lee
H 指数:49论文数:345被引数:1.4万
S
Sung Hoon Sim
H 指数:23论文数:140被引数:1,503
J
Jungsil Ro
H 指数:59论文数:248被引数:2.0万
S
So‐Youn Jung
H 指数:37论文数:249被引数:3,920
J
Joohyuk Sohn
H 指数:59论文数:635被引数:2.7万
K
Kyung Hae Jung
H 指数:55论文数:453被引数:1.5万
S
Seeyoun Lee
H 指数:28论文数:89被引数:2,288
Y
Youngmee Kwon
H 指数:30论文数:127被引数:2,731
S
Seock‐Ah Im
H 指数:98论文数:1,144被引数:6.9万
J
Jee Hyun Kim
H 指数:53论文数:491被引数:1.4万